Aerosol applicator
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a front perspective view as viewed from below, of an aerosol applicator showing our new design.
FIG. 2 is a view thereof similar to FIG. 1, showing the aerosol applicator in the open position;
FIG. 3 is a top plan view thereof;
FIG. 4 is a front elevational view thereof;
FIG. 5 is a right side view, the left side view being a mirror image thereof;
FIG. 6 is a rear elevational view thereof; and
FIG. 7 is a bottom plan view thereof.
Referenced Cited
Patent History
Patent number: D302111
Type: Grant
Filed: Jan 27, 1986
Date of Patent: Jul 11, 1989
Assignee: Glaxo Group Limited (London)
Inventors: Robert E. Newell (Pinner), Paul K. Rand (Hitchin), Carole A. Osterweil (London)
Primary Examiner: Louis S. Zarfas
Assistant Examiner: R. Seifert
Law Firm: Darby & Darby
Application Number: 6/822,828
Type: Grant
Filed: Jan 27, 1986
Date of Patent: Jul 11, 1989
Assignee: Glaxo Group Limited (London)
Inventors: Robert E. Newell (Pinner), Paul K. Rand (Hitchin), Carole A. Osterweil (London)
Primary Examiner: Louis S. Zarfas
Assistant Examiner: R. Seifert
Law Firm: Darby & Darby
Application Number: 6/822,828
Classifications
Current U.S. Class:
D/9300